ATENOLOL AND CHLORTHALIDONE
Clinical safety rating: caution
Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause hypokalemia and hyponatremia.
Atenolol is a cardioselective beta-1 adrenergic receptor antagonist that reduces heart rate, myocardial contractility, and blood pressure. Chlorthalidone is a thiazide-like diuretic that inhibits sodium and chloride reabsorption in the distal convoluted tubule, reducing plasma volume and peripheral resistance.
| Metabolism | Atenolol is minimally metabolized in the liver (mostly excreted unchanged in urine); chlorthalidone is excreted unchanged in urine (no significant hepatic metabolism). |
| Excretion | Atenolol: ~50% eliminated unchanged in urine; Chlorthalidone: ~50-70% eliminated unchanged in urine, remainder as metabolites via renal and biliary routes (<10% fecal). |
| Half-life | Atenolol: 6-7 hours (prolonged to 14-27 hours in severe renal impairment); Chlorthalidone: 40-60 hours (allows once-daily dosing). |
| Protein binding | Atenolol: <5% bound (low); Chlorthalidone: ~75% bound to albumin and erythrocytes. |
| Volume of Distribution | Atenolol: 0.7-1.2 L/kg (hydrophilic, distributes mainly in extracellular fluid); Chlorthalidone: 3-4 L/kg (large due to tissue binding). |
| Bioavailability | Atenolol: ~50-60% orally (not affected by food); Chlorthalidone: ~65% orally. |
| Onset of Action | Oral: Atenolol 1-2 hours (beta-blockade); Chlorthalidone 2-3 hours (diuresis). |
| Duration of Action | Atenolol: 24 hours (beta-blockade); Chlorthalidone: 48-72 hours (diuresis). |
1 tablet (atenolol 50 mg/chlorthalidone 25 mg) orally once daily. May be increased to 2 tablets once daily.
| Dosage form | TABLET |
| Renal impairment | Contraindicated if CrCl <30 mL/min. If CrCl 30-50 mL/min: reduce dose or increase interval; maximum atenolol 50 mg daily. |
| Liver impairment | No specific adjustment for Child-Pugh classification; use caution in severe hepatic impairment due to chlorthalidone. |
| Pediatric use | Safety and efficacy not established. Not recommended for use in pediatric patients. |
| Geriatric use | Start at lowest dose (atenolol 25 mg/chlorthalidone 12.5 mg) once daily; titrate slowly. Monitor renal function. |
| 1st trimester | Consult provider |
| 2nd trimester | Consult provider |
| 3rd trimester | Consult provider |
Clinical note
Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause hypokalemia and hyponatremia.
| FDA category | Animal |
| Breastfeeding | Atenolol: M/P ratio approximately 1.5-4.6, accumulates in breast milk, may cause bradycardia and hypotension in infant. Chlorthalidone: Excreted in breast milk, may suppress lactation. Avoid breastfeeding or use caution. |
| Teratogenic Risk | First trimester: Limited data; beta-blockers associated with intrauterine growth restriction (IUGR) if used later. Second/third trimester: Exposure may cause fetal bradycardia, hypoglycemia, and reduced placental perfusion. Chlorthalidone is contraindicated due to risk of neonatal thrombocytopenia, electrolyte disturbances, and decreased placental perfusion. |
■ FDA Black Box Warning
Abrupt withdrawal of beta-blockers may exacerbate angina and increase risk of myocardial infarction in patients with coronary artery disease. Taper dose gradually.
| Common Effects | Sleepiness Headache Ankle swelling Flushing sense of warmth in the face ears neck and trunk Slow heart rate Palpitations Nausea Edema swelling Constipation Tiredness Cold extremities |
| Serious Effects |
["Cardiogenic shock","Sinus bradycardia","Heart block greater than first degree","Decompensated heart failure","Bronchial asthma or chronic obstructive pulmonary disease (severe)","Anuria or severe renal impairment (chlorthalidone component)","Hypersensitivity to any component"]
| Precautions | ["Risk of bradycardia, heart block, and hypotension; avoid in patients with sinus bradycardia, heart block greater than first degree, or decompensated heart failure.","May exacerbate peripheral arterial insufficiency; use caution in patients with severe peripheral vascular disease.","Chlorthalidone may cause electrolyte imbalances (hypokalemia, hyponatremia, hypomagnesemia), hyperuricemia, and hyperglycemia.","Abrupt discontinuation may induce rebound hypertension or angina.","Risk of anaphylactic reactions; patients with a history of anaphylaxis may be more reactive to allergens."] |
Loading safety data…
| Fetal Monitoring | Monitor maternal blood pressure, heart rate, electrolytes, and renal function. Fetal: ultrasound for growth, amniotic fluid index, and fetal heart rate monitoring for bradycardia. Neonatal: observe for hypotension, bradycardia, hypoglycemia, and electrolyte imbalance. |
| Fertility Effects | Atenolol may rarely impair male fertility (reduced sperm motility). Chlorthalidone has no known direct effect on fertility. In females, uncontrolled hypertension may impair placental perfusion causing pregnancy complications. |
| Food/Dietary | Avoid excessive intake of potassium-rich foods (bananas, oranges, spinach, potatoes) unless hypokalemic; chlorthalidone depletes potassium, but combination may require monitoring. Limit alcohol and salt intake to enhance antihypertensive effect. Grapefruit juice may reduce atenolol absorption; space at least 4 hours apart. Maintain adequate hydration to prevent dehydration from diuresis. |
| Clinical Pearls | Atenolol is a beta-1 selective blocker; chlorthalidone is a thiazide-like diuretic. Combination reduces BP additively. Monitor heart rate (bradycardia risk), serum potassium (hypokalemia common with chlorthalidone), and renal function. Avoid in asthma (atenolol can trigger bronchospasm) and anuria. Taper beta blocker gradually to avoid rebound hypertension. |
| Patient Advice | Take exactly as prescribed, usually once daily in the morning to avoid nighttime urination. · Do not stop abruptly; sudden discontinuation may cause chest pain or heart attack. · Monitor for lightheadedness, especially when standing up quickly (orthostatic hypotension). · Report slow heart rate (<55 bpm), fainting, or difficulty breathing. · Atenolol may mask signs of hypoglycemia (tachycardia) in diabetic patients; monitor blood glucose closely. · Chlorthalidone increases urination; take in the morning to minimize sleep disruption. · Avoid potassium supplements or salt substitutes unless directed by your doctor (risk of hyperkalemia if used with NSAIDs or ACE inhibitors). · Use sunscreen and protective clothing; chlorthalidone increases photosensitivity. · May cause dizziness or fatigue; avoid driving until you know how this drug affects you. · Keep all follow-up appointments for blood pressure checks and lab tests (potassium, renal function). |